Hallal David
Insider CIK 1457477 · SEER Director · SRRK Chief Executive Officer, Director · ALVR Chief Executive Officer, Director, 10% owner · ITOS Director · ALXN SVP. Global Commercial Ops, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corp | G Gift | 2026-09-21 | 2026-09-23 | 36,652 | — | $0 | 1,602,382 | SEC↗ |
| SRRK Scholar Rock Holding Corp | G Gift | 2026-09-21 | 2026-09-23 | 36,652 | — | $0 | 1,602,382 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 9,000 | — | $0 | 9,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-04-16 | 2026-04-20 | 30,615 | $49.57 | $1.52M | 1,639,034 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2026-02-09 | 2026-02-11 | 128,004 | — | $0 | 1,669,649 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-01-13 | 2026-01-15 | 57,450 | $42.70 | $2.45M | 1,541,645 | SEC↗ |
| SRRK Scholar Rock Holding Corp | G Gift | 2025-10-08 | 2025-10-09 | 205,000 | — | $0 | 1,599,095 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 25,140 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 146,160 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-06 | 2025-06-06 | 38,228 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-06 | 2025-06-06 | 38,228 | $10.24 | $391.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-06 | 2025-06-06 | 38,228 | $4.30 | $164.4K | 38,228 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-05 | 2025-06-06 | 38,227 | — | $0 | 38,228 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-05 | 2025-06-06 | 38,227 | $10.15 | $388.0K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-05 | 2025-06-06 | 38,227 | $4.30 | $164.4K | 38,227 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2025-06-04 | 2025-06-06 | 38,227 | — | $0 | 76,455 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-06-04 | 2025-06-06 | 38,227 | $10.07 | $384.9K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2025-06-04 | 2025-06-06 | 38,227 | $4.30 | $164.4K | 38,227 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-05-02 | 2025-05-06 | 275,167 | — | $0 | 275,167 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 250,000 | — | $0 | 554,095 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 1,250,000 | — | $0 | 1,804,095 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 304,095 | SEC↗ |
| SEER Seer, Inc. | A Award | 2024-06-12 | 2024-06-14 | 58,178 | — | $0 | 355,128 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2024-06-06 | 2024-06-07 | 35,000 | — | $0 | 2,143,662 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2023-06-21 | 2023-06-22 | 36,000 | — | $0 | 36,000 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 34,735 | — | $0 | 34,735 | SEC↗ |
| SEER Seer, Inc. | A Award | 2023-06-14 | 2023-06-16 | 23,443 | — | $0 | 296,950 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2023-05-11 | 2023-05-12 | 35,000 | — | $0 | 2,108,662 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-10-19 | 2022-10-21 | 600,000 | $8.45 | $5.07M | 138,153 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-09-29 | 2022-09-30 | 400,000 | $7.35 | $2.94M | 720,965 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 3,253,796 | $4.61 | $15.00M | 16,674,766 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-07-21 | 2022-07-21 | 4,227 | $5.33 | $22.5K | 2,073,662 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-06-16 | 2022-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 29,640 | — | $0 | 29,640 | SEC↗ |
| SEER Seer, Inc. | A Award | 2022-06-15 | 2022-06-17 | 9,945 | — | $0 | 273,507 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-06-09 | 2022-06-10 | 1,171 | — | $0 | 146,160 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-06-09 | 2022-06-10 | 1,171 | $19.51 | $22.8K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-06-09 | 2022-06-10 | 1,171 | $4.23 | $5.0K | 1,171 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-06-08 | 2022-06-10 | 5,968 | — | $0 | 157,908 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-06-08 | 2022-06-10 | 11,899 | — | $0 | 25,140 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-06-08 | 2022-06-10 | 10,577 | — | $0 | 147,331 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-06-08 | 2022-06-10 | 11,899 | $2.95 | $35.1K | 11,899 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-06-08 | 2022-06-10 | 5,968 | $20.39 | $121.7K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-06-08 | 2022-06-10 | 5,968 | $4.23 | $25.2K | 5,968 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-06-08 | 2022-06-10 | 10,577 | $19.86 | $210.1K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-06-08 | 2022-06-10 | 11,899 | $20.39 | $242.6K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-06-08 | 2022-06-10 | 10,577 | $4.23 | $44.7K | 10,577 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-06-03 | 2022-06-06 | 65,725 | $3.67 | $241.2K | 2,077,889 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-05-26 | 2022-05-27 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-05-17 | 2022-05-19 | 27,500 | — | $0 | 27,500 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-04-21 | 2022-04-22 | 4,227 | $5.87 | $24.8K | 2,143,614 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-03-11 | 2022-03-11 | 25,244 | $7.37 | $186.0K | 2,147,841 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-03-10 | 2022-03-11 | 40,481 | $7.55 | $305.6K | 2,173,085 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-01-24 | 2022-01-25 | 17,100 | $8.01 | $137.0K | 2,213,566 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-20 | 2021-12-22 | 30,000 | — | $0 | 37,039 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-12-20 | 2021-12-22 | 20,000 | — | $0 | 114,682 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-20 | 2021-12-22 | 20,000 | $4.30 | $86.0K | 20,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-12-20 | 2021-12-22 | 30,000 | $2.95 | $88.5K | 50,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-20 | 2021-12-22 | 50,000 | $43.57 | $2.18M | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 16,608 | — | $0 | 16,608 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2021-05-27 | 2021-06-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2021-05-25 | 2021-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 273,000 | — | $0 | 273,000 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2021-01-21 | 2021-01-25 | 147,000 | — | $0 | 2,230,666 | SEC↗ |
| SEER Seer, Inc. | A Award deriv | 2020-12-03 | 2020-12-11 | 18,691 | — | $0 | 18,691 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-05 | 1,100,000 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-05 | 20,000,000 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-05 | 233,333 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-05 | 738,153 | — | $0 | 738,153 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-05 | 13,420,970 | — | $0 | 13,420,970 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-05 | 156,577 | — | $0 | 1,120,965 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2020-07-29 | 2020-07-31 | 1,101,000 | — | $0 | 1,101,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-10-21 | 16,608 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 16,608 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2020-06-16 | 2020-06-18 | 7,000 | — | $0 | 7,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2020-06-16 | 2020-06-18 | 13,000 | — | $0 | 13,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | G Gift | 2019-09-18 | 2019-09-20 | 2,000 | — | $0 | 290,595 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2019-05-21 | 2019-05-23 | 10,158 | — | $0 | 10,158 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2018-06-22 | 2018-06-26 | 20,316 | — | $0 | 20,316 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-08-08 | 2016-08-10 | 332 | $137.14 | $45.5K | 189,266 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-04-01 | 2016-04-05 | 34 | $136.21 | $4.6K | 189,598 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-04-01 | 2016-04-05 | 1,380 | $135.87 | $187.5K | 189,632 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 14 | $141.45 | $2.0K | 191,012 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 2,000 | $138.91 | $277.8K | 191,026 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-02-26 | 2016-03-01 | 131,000 | $140.16 | $18.36M | 131,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-26 | 2016-03-01 | 20,000 | — | $0 | 193,026 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 3,492 | $138.02 | $482.0K | 173,026 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 117 | $139.18 | $16.3K | 176,518 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 337 | $138.02 | $46.5K | 176,635 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 110 | $145.01 | $16.0K | 183,584 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 400 | $144.45 | $57.8K | 183,184 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 300 | $143.45 | $43.0K | 182,884 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 712 | $142.35 | $101.4K | 182,172 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 1,490 | $140.49 | $209.3K | 176,972 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 3,710 | $141.40 | $524.6K | 178,462 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-04 | 2016-02-08 | 619 | $143.81 | $89.0K | 142,568 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-04 | 2016-02-08 | 10 | $145.05 | $1.5K | 142,558 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-04 | 2016-02-08 | 41,136 | — | $0 | 183,694 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-07 | 2015-08-11 | 329 | $190.01 | $62.5K | 143,187 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-04 | 2015-08-05 | 612 | $196.52 | $120.3K | 143,516 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-03-31 | 2015-04-02 | 49,275 | $173.30 | $8.54M | 49,275 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-03-31 | 2015-04-02 | 11,270 | — | $0 | 144,128 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-03-02 | 2015-03-03 | 730 | $180.34 | $131.6K | 132,858 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 7,626 | — | $0 | 7,626 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 32,200 | — | $0 | 32,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 2,265 | — | $0 | 133,588 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 7,290 | — | $0 | 131,323 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,980 | $171.15 | $338.9K | 124,033 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-09 | 2015-02-09 | 2,920 | $173.93 | $507.9K | 126,013 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-05 | 2015-02-09 | 11,690 | — | $0 | 128,933 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-04 | 2015-02-05 | 608 | $174.38 | $106.0K | 117,243 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-03 | 2015-02-05 | 765 | $174.02 | $133.1K | 117,851 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-18 | 2014-12-19 | 5,494 | $182.03 | $1.00M | 113,122 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-03 | 2014-11-04 | 14,336 | $17.65 | $253.0K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-03 | 2014-11-04 | 15,664 | $22.90 | $358.7K | 84,336 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-03 | 2014-11-04 | 15,664 | $22.90 | $358.7K | 134,280 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 15,664 | $190.00 | $2.98M | 132,952 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 14,336 | $190.02 | $2.72M | 118,616 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-03 | 2014-11-04 | 14,336 | $17.65 | $253.0K | 148,616 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-08-04 | 2014-08-05 | 1,349 | $158.00 | $213.1K | 118,616 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 49,200 | — | $0 | 49,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 6,000 | — | $0 | 119,965 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 1,600 | $155.55 | $248.9K | 113,975 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 10 | $158.05 | $1.6K | 113,965 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-06 | 2014-02-10 | 10 | $156.95 | $1.6K | 113,965 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-06 | 2014-02-10 | 9,745 | — | $0 | 115,575 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-04 | 2014-02-05 | 2,390 | $153.63 | $367.2K | 105,830 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 729 | $157.14 | $114.6K | 108,220 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 29 | $133.37 | $3.9K | 108,949 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 700 | $133.45 | $93.4K | 108,978 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-18 | 2013-12-20 | 15,363 | $17.98 | $276.2K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-18 | 2013-12-20 | 7,295 | $17.98 | $131.2K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-12-18 | 2013-12-20 | 15,363 | $17.98 | $276.2K | 125,041 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-12-18 | 2013-12-20 | 7,295 | $17.98 | $131.2K | 116,973 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-18 | 2013-12-20 | 7,295 | $127.53 | $930.3K | 109,678 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-18 | 2013-12-20 | 15,363 | $127.61 | $1.96M | 109,678 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 10,705 | $17.98 | $192.5K | 7,295 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 14,637 | $17.98 | $263.2K | 15,363 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-09 | 2013-12-11 | 14,637 | $127.63 | $1.87M | 109,678 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-12-09 | 2013-12-11 | 14,637 | $17.98 | $263.2K | 124,315 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-09 | 2013-12-11 | 10,705 | $127.63 | $1.37M | 109,678 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-12-09 | 2013-12-11 | 10,705 | $17.98 | $192.5K | 120,383 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-10-28 | 2013-10-30 | 18,000 | $17.98 | $323.6K | 18,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 22,037 | $122.79 | $2.71M | 96,141 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-10-28 | 2013-10-30 | 30,000 | $17.98 | $539.4K | 118,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 4,777 | $123.77 | $591.2K | 88,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 13,223 | $122.79 | $1.62M | 92,955 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-10-28 | 2013-10-30 | 18,000 | $17.98 | $323.6K | 106,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 7,963 | $123.77 | $985.6K | 88,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-05 | 2013-08-07 | 730 | $116.87 | $85.3K | 88,178 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-30 | 2013-08-01 | 746 | $110.86 | $82.7K | 88,908 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-07-12 | 2013-07-16 | 50,000 | $17.65 | $882.5K | 14,336 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-12 | 2013-07-16 | 50,000 | $120.00 | $6.00M | 89,654 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-12 | 2013-07-16 | 50,000 | $17.65 | $882.5K | 139,654 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-06-05 | 2013-06-07 | 5,664 | $17.65 | $100.0K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-06-05 | 2013-06-07 | 5,692 | $11.92 | $67.8K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-06-05 | 2013-06-07 | 3,128 | $10.29 | $32.2K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-06-05 | 2013-06-07 | 524 | $8.16 | $4.3K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-06-05 | 2013-06-07 | 5,664 | $17.65 | $100.0K | 89,654 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-06-05 | 2013-06-07 | 5,692 | $11.92 | $67.8K | 83,990 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-06-05 | 2013-06-07 | 3,128 | $10.29 | $32.2K | 78,298 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-06-05 | 2013-06-07 | 524 | $8.16 | $4.3K | 75,170 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-02-06 | 2013-02-08 | 73,000 | — | $0 | 73,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 5,400 | — | $0 | 74,646 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 985 | $96.74 | $95.3K | 69,246 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 1,100 | $95.68 | $105.2K | 70,231 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 512 | $94.32 | $48.3K | 71,331 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 632 | $94.50 | $59.7K | 71,843 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-10-24 | 2012-10-26 | 10,500 | — | $0 | 524 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-10-24 | 2012-10-26 | 10,500 | $8.16 | $85.7K | 72,475 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-31 | 2012-07-31 | 680 | $104.99 | $71.4K | 61,975 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 50,000 | — | $0 | 64,336 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 50,000 | $17.65 | $882.5K | 113,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 50,000 | $107.74 | $5.39M | 63,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 555 | $106.14 | $58.9K | 62,655 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-15 | 2012-06-19 | 14,308 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-06-15 | 2012-06-19 | 14,308 | $11.92 | $170.6K | 77,518 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-06-15 | 2012-06-19 | 14,308 | $93.67 | $1.34M | 63,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-09 | 2012-05-11 | 10,000 | — | $0 | 84,710 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-09 | 2012-05-11 | 10,000 | $8.16 | $81.6K | 63,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-23 | 2012-02-24 | 40,000 | — | $0 | 14,308 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-23 | 2012-02-24 | 40,000 | $11.92 | $476.8K | 93,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-23 | 2012-02-24 | 40,000 | $85.50 | $3.42M | 53,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-03 | 2012-02-06 | 77,000 | — | $0 | 77,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 10,000 | — | $0 | 53,210 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-30 | 2012-01-30 | 1,896 | $74.51 | $141.3K | 39,749 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-27 | 2012-01-30 | 554 | $74.41 | $41.2K | 41,645 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-10 | 2012-01-11 | 536 | $75.00 | $40.2K | 42,199 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2011-12-30 | 2012-01-04 | 3,000 | — | $0 | 21,024 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2011-12-30 | 2012-01-04 | 3,000 | $8.16 | $24.5K | 42,735 | SEC↗ |